Core Insights - General Dynamics is a strong candidate for investors looking for stocks that consistently beat earnings estimates, particularly in the Aerospace-Defense industry [1] Earnings Performance - For the most recent quarter, General Dynamics reported earnings of $3.47 per share, missing the expected $3.66 per share by 5.48%. In the previous quarter, the company exceeded expectations with earnings of $4.15 per share against a consensus estimate of $4.13 per share, resulting in a surprise of 0.48% [2] Earnings Estimates and Predictions - There has been a favorable change in earnings estimates for General Dynamics, with a positive Zacks Earnings ESP of +6.19%, indicating analysts' bullish sentiment regarding the company's earnings prospects [5][8] - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) suggests a high likelihood of another earnings beat, with historical data showing that such combinations lead to positive surprises nearly 70% of the time [6][8] Importance of Earnings ESP - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions, which may provide more accurate predictions [7] - Monitoring the Earnings ESP before quarterly releases is crucial for increasing the odds of successful investments [10]

Group 1 - The core viewpoint is that Hershey (HSY) is well-positioned to continue its earnings-beat streak in the upcoming report, supported by a history of exceeding earnings estimates [1][5] - Hershey has an average surprise of 10.38% over the past two quarters, indicating strong performance relative to expectations [1][5] - The last reported quarter showed earnings of $2.09 per share, surpassing the Zacks Consensus Estimate of $1.94 per share by 7.73% [2] Group 2 - The previous quarter's earnings were $2.69 per share against an expectation of $2.38 per share, resulting in a surprise of 13.03% [2] - There has been a favorable change in earnings estimates for Hershey, with a positive Earnings ESP of +11.13%, suggesting analysts are optimistic about its near-term earnings potential [5][8] - The combination of a positive Earnings ESP and a Zacks Rank 3 (Hold) indicates a high likelihood of another earnings beat, with historical data showing nearly 70% success in similar scenarios [6][8]

Core Insights - DTE Energy has consistently surpassed earnings estimates, making it a strong candidate for potential investment opportunities in the utility sector [1][2]. Earnings Performance - In the last reported quarter, DTE Energy achieved earnings of $2.1 per share, exceeding the Zacks Consensus Estimate of $1.98 per share by 6.06% [2]. - In the previous quarter, the company reported earnings of $1.51 per share against an expected $1.46 per share, resulting in a surprise of 3.42% [2]. Earnings Estimates and Predictions - Recent estimates for DTE Energy have been increasing, with a positive Earnings ESP of +3.14%, indicating bullish sentiment among analysts regarding its near-term earnings potential [5][8]. - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) suggests a high likelihood of another earnings beat [5][8]. Statistical Insights - Research indicates that stocks with a positive Earnings ESP and a Zacks Rank of 3 or better have a nearly 70% chance of producing a positive surprise [6]. - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions [7].

Core Viewpoint - The PNC Financial Services Group, Inc. is positioned well to potentially beat earnings estimates in its upcoming quarterly report, continuing a strong trend of surpassing expectations [1]. Earnings Performance - The company has consistently exceeded earnings estimates, with an average surprise of 8.74% over the last two quarters [2]. - In the last reported quarter, PNC achieved earnings of $3.51 per share, surpassing the Zacks Consensus Estimate of $3.4 per share by 3.24%. In the previous quarter, it reported earnings of $3.77 per share against an expectation of $3.3 per share, resulting in a surprise of 14.24% [3]. Earnings Estimates and Predictions - Recent changes in earnings estimates for PNC have been favorable, with a positive Earnings ESP (Expected Surprise Prediction) indicating a strong likelihood of an earnings beat [6]. - The current Earnings ESP for PNC is +0.25%, suggesting increased analyst optimism regarding its near-term earnings potential. This, combined with a Zacks Rank of 3 (Hold), indicates a good chance of another earnings beat [9]. Statistical Insights - Research indicates that stocks with a positive Earnings ESP and a Zacks Rank of 3 or better have a nearly 70% success rate in producing positive surprises [7]. - The Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions, which may be more accurate [8].

Core Viewpoint - C.H. Robinson Worldwide (CHRW) is positioned well to potentially beat earnings estimates in its upcoming quarterly report, continuing a strong trend of surpassing expectations in recent quarters [1]. Group 1: Earnings Performance - C.H. Robinson has consistently exceeded earnings estimates, with an average surprise of 11.37% over the last two quarters [2]. - In the last reported quarter, the company achieved earnings of $1.17 per share, surpassing the Zacks Consensus Estimate of $1.02 per share by 14.71% [3]. - In the previous quarter, the company reported earnings of $1.21 per share against an expected $1.12 per share, resulting in a surprise of 8.04% [3]. Group 2: Earnings Estimates and Predictions - Earnings estimates for C.H. Robinson have been trending higher, influenced by its history of earnings surprises [6]. - The company currently has an Earnings ESP of +0.40%, indicating a bullish outlook from analysts regarding its earnings prospects [9]. - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) suggests a strong possibility of another earnings beat [9]. Group 3: Earnings ESP Insights - Stocks with a positive Earnings ESP and a Zacks Rank of 3 or better have a nearly 70% chance of producing a positive surprise [7]. - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, reflecting the latest analyst revisions [8]. - A negative Earnings ESP does not necessarily indicate an earnings miss but can reduce the predictive power of the metric [9].

Core Viewpoint - KeyCorp (KEY) has a strong track record of exceeding earnings estimates, making it a potential candidate for investors looking for consistent performance in the upcoming quarterly report [1][5]. Earnings Performance - In the most recent quarter, KeyCorp reported earnings of $0.32 per share, slightly below the expected $0.33, resulting in a surprise of 3.13% [2]. - In the previous quarter, the company exceeded expectations by reporting $0.38 per share against a consensus estimate of $0.33, achieving a surprise of 15.15% [2]. Earnings Estimates and Predictions - There has been a favorable shift in earnings estimates for KeyCorp, with a positive Earnings ESP (Expected Surprise Prediction) indicating a strong likelihood of an earnings beat [5][8]. - The current Earnings ESP for KeyCorp is +1.36%, suggesting that analysts have recently become more optimistic about the company's earnings prospects [8]. Zacks Rank and Success Rate - KeyCorp holds a Zacks Rank of 3 (Hold), which, when combined with a positive Earnings ESP, historically leads to a positive surprise rate of nearly 70% [6][8]. - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions [7]. Upcoming Earnings Report - The next earnings report for KeyCorp is expected to be released on July 21, 2025 [8].

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Nurix Therapeutics, Inc. (NRIX) due to higher revenues, with a focus on how actual results will compare to estimates [1][3]. Earnings Expectations - The consensus estimate predicts a quarterly loss of $0.70 per share, reflecting a year-over-year change of +1.4% [3][19]. - Expected revenues are $19.81 million, which represents a significant increase of 63.9% from the same quarter last year [3][19]. Estimate Revisions - The consensus EPS estimate has remained unchanged over the last 30 days, indicating stability in analyst expectations [4][19]. - The Most Accurate Estimate is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +4.74%, suggesting a bullish outlook from analysts [12][19]. Earnings Surprise Potential - A positive Earnings ESP reading indicates a higher likelihood of an earnings beat, especially when combined with a Zacks Rank of 2 (Buy) [10][12]. - Nurix Therapeutics has a Zacks Rank of 2, enhancing the probability of surpassing the consensus EPS estimate [12][20]. Historical Performance - In the last reported quarter, Nurix Therapeutics was expected to post a loss of $0.72 per share but actually reported a loss of -$0.67, resulting in a surprise of +6.94% [13]. - Over the past four quarters, the company has only beaten consensus EPS estimates once [14].

Wall Street expects a year-over-year decline in earnings on lower revenues when Delta Air Lines (DAL) reports results for the quarter ended June 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 10. On t ...

Core Viewpoint - Boston Scientific (BSX) is positioned well to potentially beat earnings estimates in its upcoming quarterly report, supported by a strong history of exceeding expectations [1][6]. Earnings Performance - The company has a solid track record of surpassing earnings estimates, with an average surprise of 9.82% over the last two quarters [2]. - In the last reported quarter, Boston Scientific achieved earnings of $0.75 per share, exceeding the Zacks Consensus Estimate of $0.67 per share by 11.94% [3]. - For the previous quarter, the company reported earnings of $0.70 per share against an expectation of $0.65 per share, resulting in a surprise of 7.69% [3]. Earnings Estimates and Predictions - Recent estimates for Boston Scientific have been trending upward, indicating positive sentiment among analysts [6]. - The Zacks Earnings ESP for the company is currently +0.88%, suggesting increased bullishness regarding its near-term earnings potential [9]. - The combination of a positive Earnings ESP and a Zacks Rank of 2 (Buy) indicates a strong likelihood of another earnings beat [9]. Statistical Insights - Research indicates that stocks with a positive Earnings ESP and a Zacks Rank of 3 (Hold) or better have a nearly 70% chance of producing a positive surprise [7]. - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with the Most Accurate Estimate reflecting the latest analyst revisions [8].

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Alphabet (GOOGL) , which belongs to the Zacks Internet - Services industry.When looking at the last two reports, this internet search leader has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 20.26%, on average, in the last two quarters.For the most recent quarter, Alphabet was expected to post earnings of $2.81 ...